Partner, U.S. National Healthcare and Life Sciences Deal Advisory and Strategy Leader, KPMG US
Alex Neil
Partner, U.S. National Healthcare and Life Sciences Deal Advisory and Strategy Leader
Alex is a well-respected and successful leader with 25 years of experience providing professional services to a global client base of institutions with a focus on the Healthcare Lifesciences ("HCLS") industry. As the U.S. Deal Advisory & Strategy Sector Leader for Healthcare & Lifesciences, Alex delivers value driven client solutions across M&A transactions, capital markets transactions and regulatory changes. Alex previously served as the Accounting Advisory Services HCLS Service Network lead where he focused on market, client, and people driven dynamics facing the business. Alex's experience includes providing accounting and financial reporting advisory services under US GAAP and IFRS focusing on merger & acquisition (“M&A”) transactions, complex capital raising and financing structures, financial instruments, stock compensation, revenue recognition and leasing.
Professional and Industry Experience
• In addition to his Deal Advisory and Strategy leadership role, Alex leads KPMG’s Accounting Advisory team in the Pacific Southwest, and he previously led KPMG’s National Accounting Advisory Healthcare and Lifesciences team.
• Alex has extensive experience in advising clients on accounting and financial reporting considerations for M&A transactions, including accounting structuring, conversions between US GAAP and IFRS, and SEC filing requirements.
• Alex has deep experience in capital markets transactions, assisting clients with accounting and financial reporting requirements for regulatory filings and public company readiness.
• Alex has led various projects related to implementing accounting standards such as ASC 606 (revenue recognition), ASC 842 (lease), ASC 326 (credit loss), and IFRS conversion projects for large US subsidiaries.
• Alex has significant experience in evaluating accounting and financial reporting considerations for complex debt and equity capital raisings, as well as providing consultation on financial instruments, stock-based compensation, revenue recognition, consolidations, investments, licenses, collaborations, and R&D funding arrangements.
• Alex also advises clients on accounting policy development, financial reporting processes and controls, including assisting in the development of accounting policy manuals, financial statement preparation processes, stock compensation processes, and cash flow statement processes.